Ventyx Biosciences, Inc. Profile Avatar - Palmy Investing

Ventyx Biosciences, Inc.

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that i…

Biotechnology
US, Encinitas [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of VTYX's Analysis
CIK: 1851194 CUSIP: 92332V107 ISIN: US92332V1070 LEI: - UEI: -
Secondary Listings
VTYX has no secondary listings inside our databases.